France· FR:64955133
TIVICAY 5 mg, comprimé dispersible
A medicinal product containing dolutégravir sodique, registered in France by VIIV HEALTHCARE (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DOLUTÉGRAVIR SODIQUE
- Manufacturer
- VIIV HEALTHCARE (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302203061 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 comprimé(s) + 1 godet doseur + 1 seringue pour administration oraleEUR 165.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dolutégravir sodique in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTivicay PDViiV Healthcare Company
- CanadaTIVICAYVIIV HEALTHCARE ULC
- SwitzerlandTivicay 5 mg, Tabletten zur Herstellung einer Suspension zum EinnehmenViiV Healthcare GmbH
- SpainTIVICAY 5 MG COMPRIMIDOS DISPERSABLESViiv Healthcare B.V.
- FinlandTivicayViiV Healthcare BV
- BelgiumTivicay 5 mgViiV Healthcare
- IrelandTivicay 5 mg dispersible tabletsViiV Healthcare BV
- NorwayTivicayViiV Healthcare BV (1)
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Cyprus · Dogrivio
- Iceland · Tivicay
- Liechtenstein · Tivicay
- Norway · Dolutegravir Teva, Tivicay
- Sweden · Dogrivio, Dolutegravir Elpen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/40e53e75-28c8-4a5a-8227-a7c3a23cb634 GET /v1/drugs/40e53e75-28c8-4a5a-8227-a7c3a23cb634?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64955133",
"date_amm": "2021-01-11",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/13/892",
"substance": "DOLUTÉGRAVIR SODIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé dispersible",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about dolutégravir sodique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.